Ki. Rother et al., EVIDENCE THAT IRS-2 PHOSPHORYLATION IS REQUIRED FOR INSULIN ACTION INHEPATOCYTES, The Journal of biological chemistry, 273(28), 1998, pp. 17491-17497
Insulin receptor substrates (IRSs) are tyrosine-phosphorylated followi
ng stimulation with insulin, insulinlike growth factors (IGFs), and in
terleukins. A key questionis whether different IRSs play different rol
es to mediate insulin's metabolic and growth-promoting effects. In a n
ovel system of insulin receptor-deficient hepatocytes, insulin fails t
o (i) stimulate glucose phosphorylation, (ii) enhance glycogen synthes
is, (iii) suppress glucose production, and (iv) promote mitogenesis, H
owever, insulin's ability to induce IRS-1 and gab-1 phosphorylation an
d binding to phosphatidylinositol (PI) 3-kinase is unaffected, by virt
ue of the compensatory actions of IGF-1 receptors, In contrast, phosph
orylation of IRS-2 and generation of IRS-2/PI 3-kinase complexes are m
arkedly reduced. Thus, absence of insulin receptors selectively reduce
s IRS-2, but not IRS-1 phosphorylation, and the impairment of IRS-S ac
tivation is associated with lack of insulin effects. To address whethe
r phosphorylation of additional IRSs is also affected, we analyzed pho
sphotyrosine-containing proteins in PI 3-kinase immunoprecipitates fro
m insulin-treated cells, However, these experiments indicate that IRS-
1 and IRS-2 are the main PI 3-kinase bound proteins in hepatocytes, Th
ese data identify IRS-2 as the main effector of both the metabolic and
growth-promoting actions of insulin through PI 3-kinase in hepatocyte
s, and IRS-1 as the main substrate mediating the mitogenic actions of
IGF-1 receptors.